Research Article| Volume 34, ISSUE 4, P449-453, August 2021

Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes

Published:January 20, 2021DOI:


      Study Objective

      Rhabdomyosarcomas (RMSs) of the female genital tract (FGT) have been recently shown to be associated with germline pathogenic variation in DICER1, which can underlie a tumor predisposition disorder. We sought to determine the incidence of a pathogenic variation in DICER1 in a cohort of RMSs of the FGT, as well as to evaluate the clinicopathological features and outcomes of the patients.

      Design, Setting, Participants, Interventions, and Main Outcome Measures

      We retrospectively reviewed medical records of the patients diagnosed with RMS of the FGT between 1990 and 2019. Molecular genetic sequencing of the tumor to detect an RNase IIIb domain hot spot mutation in DICER1 samples was performed in 7 patients. Individuals with a missense mutation in the tumor were also screened for a loss of function germline mutation in DICER1.


      Of 210 cases of pediatric RMS, 11 arose from the FGT. Molecular genetic sequencing of the tumor samples revealed a somatic missense mutation in the RNase IIIb domain of DICER1 in a total of 3 patients, 2 patients with embryonal RMS of the cervix/uterus, and 1 patient with ovarian embryonal RMS. As a result of genetic testing for the loss of function germline mutation in DICER1, a heterozygous pathogenic variant was also found in 2 of these patients.


      Despite the limited number of patients, our findings suggest that it is important to be aware of the possible association between RMS of FGT and pathogenic germline DICER1 variants because the detection of this mutation in a patient or relatives can provide the opportunity for surveillance of related conditions that might improve long-term outcomes and survival.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Villella J.A.
        • Bogner P.N.
        • Jani-Sait S.N.
        • et al.
        Rhabdomyosarcoma of the cervix in sisters with review of the literature.
        Gynecol Oncol. 2005; 99: 742
        • Zeisler H.
        • Mayorhofer K.
        • Joura E.A.
        • et al.
        Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature.
        Gynecol Oncol. 1998; 69: 78
        • Walterhouse D.O.
        • Meza J.L.
        • Breneman J.C.
        • et al.
        Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
        Pediatr Blood Cancer. 2011; 57: 76
        • Minard-Colin V.
        • Walterhouse D.
        • Bisogno G.
        • et al.
        Localized vaginal/uterine rhabdomyosarcoma—results of a pooled analysis from four international cooperative groups.
        Pediatr Blood Cancer. 2018; 65: e27096
        • de Kock L.
        • Druker H.
        • Weber E.
        • et al.
        Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
        Hum Pathol. 2015; 46: 917
        • Dehner L.P.
        • Jarzembowski J.A.
        • Hill D.A.
        Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.
        Mod Pathol. 2012; 25: 602
        • Doros L.
        • Yang J.
        • Dehner L.
        • et al.
        DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.
        Pediatr Blood Cancer. 2012; 59: 558
        • Dural O.
        • Kebudi R.
        • Yavuz E.
        • et al.
        DICER1-related embryonal rhabdomyosarcoma of the uterine corpus in a prepubertal girl.
        J Pediatr Adolesc Gynecol. 2020; 33: 173
        • Kebudi R.
        • Schultz K.A.P.
        • Shah R.
        • et al.
        Germline dicer1 mutation and sarcoma of the ovary (abstract PO-500).
        in: Presented at The 50th Annual Congress of the International Society of Paediatric Oncology (SIOP), Kyoto, JapanNovember 16-19, 2018
        • Hill D.A.
        • Ivanovich J.
        • Priest J.R.
        • et al.
        DICER1 mutations in familial pleuropulmonary blastoma.
        Science. 2009; 325: 965
        • Stewart C.J.
        • Charles A.
        • Foulkes W.D..
        Gynecologic manifestations of the DICER1 syndrome.
        Surg Pathol Clin. 2016; 9: 227
        • Brenneman M.
        • Field A.
        • Yang J.
        • et al.
        Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma /DICER1 syndrome: a unique variant of the two-hit tumor suppression model. Version 2.
        F1000Res. 2015; 4: 214
        • Schultz K.A.P.
        • Harris A.K.
        • Finch M.
        DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
        Gynecol Oncol. 2017; 147: 521
        • Merideth M.A.
        • Harney L.A.
        • Vyas N.
        • et al.
        Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
        Gynecol Oncol. 2020; 156: 647
        • Dagher R.
        • Helman L.
        Rhabdomyosarcoma: an overview.
        Oncologist. 1999; 4: 34
      1. (Edited by)
        • Wexler L.H.
        • Meyer W.H.
        • Helman L.J.
        Rhabdomyosarcoma and the undifferentiated sarcomas.
        in: Pizzo P.A. Poplack D.G. Principles and Practice of Pediatric Oncology. Lippincott Williams and Wilkins, Philadelphia2006: 972-1032 (Edited by)
        • Hill D.A.
        • Jarzembowski J.A.
        • Priest J.R.
        • et al.
        Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the International Pleuropulmonary Blastoma Registry.
        Am J Surg Pathol. 2008; 32: 282
        • Heravi-Moussavi A.
        • Anglesio M.S.
        • Cheng S.W.
        • et al.
        Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
        N Engl J Med. 2012; 366: 234
        • Tomiak E.
        • de Kock L.
        • Grynspan D.
        • et al.
        DICER1 mutations in an adolescent with cervical embryonal rhabdomyosarcoma (cERMS).
        Pediatr Blood Cancer. 2014; 61: 568
        • Schultz K.A.P.
        • Williams G.M.
        • Kamihara J.
        • et al.
        DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies.
        Clin Cancer Res. 2018; 24: 2251
        • Hill D.A.
        • Wang J.D.
        • Schoettler P.
        • et al.
        Germline DICER1 mutations are common in both hereditary and presumed sporadic pleuropulmonary blastoma.
        Lab Invest. 2010; 90: 311
        • Kirsch C.H.
        • Goodman M.
        • Esiashvili N.
        Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006.
        Am J Clin Oncol. 2014; 37: 47
        • Martelli H.
        • Oberlin O.
        • Rey A.
        • et al.
        Conservative treatment for females with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology.
        J Clin Oncol. 1999; 17: 2117
        • Walterhouse D.O.
        • Meza J.L.
        • Breneman J.C.
        • et al.
        Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
        Pediatr Blood Cancer. 2011; 57: 76
        • Walterhouse D.O.
        • Pappo A.S.
        • Meza J.L.
        • et al.
        Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
        Cancer. 2017; 123: 2368
        • Lautz T.B.
        • Martelli H.
        • Fuchs J.
        • et al.
        Local treatment of rhabdomyosarcoma of the female genital tract: expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
        Pediatr Blood Cancer. 2020; : e28601